Compare LYEL & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LYEL | SILC |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.1M | 110.7M |
| IPO Year | 2021 | 2002 |
| Metric | LYEL | SILC |
|---|---|---|
| Price | $19.20 | $18.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $27.25 | N/A |
| AVG Volume (30 Days) | ★ 93.9K | 36.6K |
| Earning Date | 03-12-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | $17.17 |
| Revenue Next Year | N/A | $12.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $12.44 |
| 52 Week High | $45.00 | $23.00 |
| Indicator | LYEL | SILC |
|---|---|---|
| Relative Strength Index (RSI) | 36.21 | 41.87 |
| Support Level | $15.82 | $14.96 |
| Resistance Level | $27.30 | $18.76 |
| Average True Range (ATR) | 2.06 | 0.98 |
| MACD | -0.41 | -0.20 |
| Stochastic Oscillator | 4.99 | 11.25 |
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.